Clinical Medical Research Center for Women and Children Diseases, Key Laboratory of Birth Defect Prevention and Genetic Medicine of Shandong Health Commission, Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan 250014, China; School of Public Health, North China University of Science and Technology, Tangshan 063000, China.
Clinical Medical Research Center for Women and Children Diseases, Key Laboratory of Birth Defect Prevention and Genetic Medicine of Shandong Health Commission, Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan 250014, China.
Biomed Pharmacother. 2024 Sep;178:117225. doi: 10.1016/j.biopha.2024.117225. Epub 2024 Jul 30.
The Activator Protein 1 (AP-1) transcription factor complex plays a pivotal role in the regulation of cancer-related genes, influencing cancer cell proliferation, invasion, migration, angiogenesis, and apoptosis. Composed of multiple subunits, AP-1 has diverse roles across different cancer types and environmental contexts, but its specific mechanisms remain unclear. The advent of multi-omics approaches has shed light on a more comprehensive understanding of AP-1's role and mechanism in gene regulation. This review collates recent genome-wide data on AP-1 and provides an overview of its expression, structure, function, and interaction across different diseases. An examination of these findings can illuminate the intricate nature of AP-1 regulation and its significant involvement in the progression of different diseases. Moreover, we discuss the potential use of AP-1 as a target for individual therapy and explore the various challenges associated with such an approach. Ultimately, this review provides valuable insights into the biology of AP-1 and its potential as a therapeutic target for cancer and disease treatments.
激活蛋白 1(AP-1)转录因子复合物在调节与癌症相关的基因中发挥着关键作用,影响癌细胞的增殖、侵袭、迁移、血管生成和凋亡。AP-1 由多个亚基组成,在不同类型的癌症和环境背景下具有多种作用,但具体机制尚不清楚。多组学方法的出现使人们对 AP-1 在基因调控中的作用和机制有了更全面的了解。本综述收集了最近关于 AP-1 的全基因组数据,并概述了其在不同疾病中的表达、结构、功能和相互作用。对这些发现的研究可以阐明 AP-1 调控的复杂性及其在不同疾病进展中的重要参与。此外,我们还讨论了将 AP-1 作为个体治疗靶点的潜力,并探讨了这种方法所涉及的各种挑战。最终,本综述为 AP-1 的生物学及其作为癌症和疾病治疗的治疗靶点的潜力提供了有价值的见解。